GET THE APP

Journal of Applied Pharmacy

Journal of Applied Pharmacy
Open Access

ISSN: 1920-4159

Editorial - (2021)Volume 13, Issue 9

Pistacia khinjuk: Antihyperlipidemic Effect

Kenza Cope*
 
*Correspondence: Kenza Cope, Department of Pharmacy, Medical University of Sofia, Bolivia, Email:

Author info »

Editorial

Hyperlipidemia is a metabolic disorder that is caused by high levels of triglycerides and cholesterol in blood. Using of plants for the treatment of various ailments is a traditional practice in developing countries. The main objective of the study is to analyse the nutritional composition of Pistacia khinjuk and to assess its antihyperlipidemic activity. In the present study, the ethanolic extract of Pistacia khinjuk leaves was evaluated for antihyperlipidemic activity.

40 adult albino rats were divided into five groups. Hyperlipidemia was induced using high fat diet for 60 days. Pistacia khinjuk extract of 150 mg/kg body weight and 300 mg/kg of body weight was administered to the rats for 28 days. Proximate analysis of Pistacia khinjuk was also performed.

Proximate analysis of Pistacia khinjuk leaves showed 6.8% ash content, 12.8% crude fiber and only 6.85% fat content. Findings of present study revealed that both doses of Pistacia khinjuk extract improved the serum lipid profile in albino rats by reducing total lipids, total cholesterol, triglycerides and low density lipoprotein, and increasing high density lipoprotein levels in Pistacia khinjuk treated groups. Body weight findings showed significant increase in body weight of all groups from zero days to 60th day. But before sacrifice, there was a decrease in hyperlipidemic and high dose Pistacia khinjuk while increase in control and low dose Pistacia khinjuk group respectively.

From the results of the present study, it is concluded that Pistacia khinjuk extract has curative effect against hyperlipidemia.

Author Info

Kenza Cope*
 
Department of Pharmacy, Medical University of Sofia, Bolivia
 

Citation: Cope K (2021) Pistacia khinjuk: Antihyperlipidemic Effect. J Appl Pharm 13:314

Received: 16-Sep-2021 Accepted: 21-Sep-2021 Published: 26-Sep-2021 , DOI: 10.35248/1920-4159.21.13.314

Copyright: © 2021 Cope K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top